B7-H4 Expression as a Predictive Biomarker in Human Cervical Cancer Immunotherapy

International Journal of Cancer Studies & Research
doi 10.19070/2167-9118-16000017
Full Text
Abstract

Available in full text

Date
Authors
Publisher

SciDoc Publishers LLC

Related search

B7-H3, a Checkpoint Molecule, as a Target for Cancer Immunotherapy

International Journal of Biological Sciences
Applied MicrobiologyEvolutionEcologyDevelopmental BiologyCell BiologyMolecular BiologySystematicsBehaviorBiotechnology
2020English

Human Papillomavirus DNA Methylation as a Potential Biomarker for Cervical Cancer

Cancer Epidemiology Biomarkers and Prevention
MedicineEpidemiologyOncology
2012English

Correction: B7-H4 as an Independent Prognostic Indicator of Cancer Patients: A Meta-Analysis

Oncotarget
Oncology
2018English

B7-H3 Expression in NSCLC and Its Association With B7-H4, PD-L1 and Tumor-Infiltrating Lymphocytes

Clinical Cancer Research
Cancer ResearchOncology
2017English

Estrogen Receptor-Alpha as a Predictive Biomarker in Endometrioid Endometrial Cancer

Gynecologic Oncology
GynecologyOncologyObstetrics
2016English

Thymidylate Synthase Expression as a Predictive Biomarker of Pemetrexed Sensitivity in Advanced Non-Small Cell Lung Cancer

BMC Pulmonary Medicine
PulmonaryRespiratory Medicine
2015English

Immunotherapy for Cervical Cancer

BioDrugs
MedicineBiotechnologyPharmacology
2010English

MRE11 as a Predictive Biomarker of Outcome Following Radiotherapy in Bladder Cancer

International Journal of Radiation Oncology Biology Physics
OncologyRadiologyCancer ResearchRadiationNuclear MedicineImaging
2019English

TCR Diversity – A Universal Cancer Immunotherapy Biomarker?

Journal for ImmunoTherapy of Cancer
OncologyMolecular MedicinePharmacologyCancer ResearchAllergyImmunology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy